What we know about the virus that's spreading across the globe.

Coronavirus

What's ahead in a post-Roe v. Wade world.

Axios Explains: Abortion

The developments that matter in how Americans are paying for drugs, treatment, insurance and more.

Health care costs

Opioids

The developments that matter in the fight over Obama's landmark health care law.

Affordable Care Act

The latest in the debate over whether the U.S. should shift to government-funded health care.

Medicare for All

The developments that matter in the fight over e-cigarette use.

Vaping

The developments that matter on issues that affect our immediate safety and health.

Public health

The U.S. faces a range of health care flashpoints — unaffordable drugs, opioids, vaping — as we debate whether to adopt universal care. For now, the Affordable Care Act is the law of the land, but Republicans want to issue it a final death blow.

Health

National

Axios Vitals

Inflation is making it harder for Americans — particularly minorities — to afford timely medical care for serious illnesses, according to a new national poll.

Why it matters: It's just one of the findings from the poll, which took up the recent consequences of inflation, particularly on minorities.

The findings suggest U.S. cities could be facing an uptick in hunger and homelessness in the next coming months if they don't prepare, said Robert Blendon, the co-director of the survey, told Axios.

"It's very striking," Blendon said. "We're in an inflationary period here and it's unusually broadly hitting minority communities even worse than everyone else."

By the numbers: The poll from NPR, The Robert Wood Johnson Foundation, and the Harvard T.H. Chan School of Public Health was conducted on a nationally representative sample of more than 4,000 adults. 

Nearly 60% of Black and Latino households and about 70% of Native American households said recent price increases caused them serious financial problems. In comparison, 36% of Asian households and 44% of White households agreed.

In the past year, 16% of Black renters, 10% of Latino renters, 21% of Native American renters say they have either been evicted or threatened with eviction. Less than 5% of Asian renters and 9% of white renters said the same.

Significant percentages of U.S. households with a member who's been seriously ill in the past year reported they were unable to get medical care for serious illnesses when needed. The proportions were: 35% Native American, 24% Black, 18% Latino, 18% white and 10% Asian. 

More than one in five Black adults (22%), one-quarter of Native American adults, 19% of Latino adults, 16% of white adults and 14% of Asian adults say they are currently having serious problems affording medical care or prescription drugs.  

Be smart: The deep racial disparities exposed during the first years of the COVID-19 don't appear to be improving in the latest phase of the pandemic — and could signal sustained societal problems.

"The gaps between Blacks and whites on getting care were the same," Blendon said.

Inflation hikes causing delayed care for minorities: poll

COVID-19

Why generic drugmakers oppose Dems' drug pricing bill

They say it will lead to less competition over time.

Prescription drugs

Indiana became the first state in the country since Roe. v. Wade was overturned to approve a near-total abortion ban Friday night.

The big picture: The ban comes after the Supreme Court's decision to overturn Roe v. Wade sent the issue of abortion rights back to the states. Many Republican states have already begun taking action to ban the procedure, but Indiana is the first to pass a bill following the ruling.

Zoom in: Indiana Gov. Eric Holcomb signed the bill into law late Friday night after the Indiana House and Senate passed the bill earlier that day. 

Under the bill, abortions can be performed at hospitals or outpatient centers owned by hospitals. This means abortion clinics will lose licenses in Indiana.

Doctors who perform an illegal abortion, or fail to report them, will also lose their licenses under the new law, the Associated Press reports.

Yes, but: The ban includes some exceptions, including cases of rape, incest, if the fetus is diagnosed to be a lethal anomaly and cases to protect the life of the mother, AP reports. 

Of note: Indiana currently allows abortions up to 20 weeks post-fertilization (or 22 weeks after the mother's last menstrual period), CNN reports.

What they're saying: White House press secretary Karine Jean-Pierre said in a statement Saturday that the Indiana legislature "took a devastating step" to "eliminate women’s constitutionally-protected right to abortion."

She said the vote is "another radical step by Republican legislators to take away women’s reproductive rights and freedom, and put personal health care decisions in the hands of politicians rather than women and their doctors."

Gov. Holcomb said in the statement that he was "most proud of each Hoosier who came forward to courageously share their views in a debate that is unlikely to cease any time soon. For my part as your governor, I will continue to keep an open ear.”

Rep. John Jacob (R), who previously supported a total abortion ban, said the abortion bill wasn't strong enough, the Indy Star reports.

 "The body inside of the mom's body is not her body," he said, per the Washington Post. Let me repeat that: The body inside of the mom's body is not her body. Not her body, not her choice."

Rep. Wendy McNamara (R), who sponsored the bill, said the new legislation “makes Indiana one of the most pro-life states in the nation.”

Rep. Renee Pack (D) told the chamber she had an abortion in 1990 and she had to choose between having an abortion or continuing her military career, the Indy Star reports. 

"Sir, I am not a murderer," she said. "And my sisters are not murderers, either. We are pro-choice. That is what we are."

Sen. Mike Bohacek (R) could not finish his testimony about the bill as he spoke about protecting rape victims with disabilities.

What to watch: Eli Lilly and Co., which is one of Indiana's largest employers, said in reaction to the ban that it will be “forced to plan for more employment growth outside of our home state.”

Jon Mills, a spokesman for engine maker Cummins, which employs 10,000 people in Indiana, said in a statement to the New York Times that the law will "impact our people and impede our ability to attract and retain top talent.”

Mills told NYT that “prior to, and during the legislative process, we shared our concerns about this legislation with legislative leadership.”

Go deeper ... Where abortion has been banned now that Roe v. Wade is overturned

The abortion trigger laws that have gone into effect now that Roe v. Wade is overturned

Editor's note: This story was updated with a statement from the White House press secretary and to add quotes from Jon Mills. 

'Not her body, not her choice': Indiana legislature passes near-total abortion ban

Indiana Gov. Eric Holcomb signed the bill into law late Friday night.

Abortion rights protesters march outside the Indiana State Capitol building.

Abortion rights protesters march outside the Indiana State Capitol building. Photo: Jon Cherry/Getty Images

Indiana

Florida's medical board voted Friday to start the process of updating its rules for banning gender-affirming medical treatment for young people.

Why it matters: The vote begins a process of updating guidance on gender-affirming treatments in Florida, which is the third most populated state in the country.

Driving the news: Florida's Board of Medicine voted Friday in a public hearing to approve the beginning stages of creating rules that will prohibit minors from receiving hormone therapy and undergoing surgeries for gender dysphoria, according to Click Orlando.

Some transgender people experience gender dysphoria when their bodies don't align with their gender, Politico reports.

The board voted to approve holding workshops, gathering data and speaking with experts to build a standard of care.

The vote allows the board to "make a decision on whether to adopt a rule that limits the use of puberty blockers, hormone treatments, and irreversible surgeries (such as double mastectomies) as treatment options for children with gender dysphoria," Jeremy Redfern, press secretary for the Florida Department of Health, told Axios in an email.

What they're saying: "The Florida Board of Medicine opened the rule-making process to review the evidence around these procedures, especially as applied to children," said Bryan Griffin, the deputy press secretary to DeSantis, in an email to Axios. "As the governor has stated, Florida will make policy based on facts. This is yet another step in the fact-finding process."

State of play: Florida's Department of Health previously said treatments like puberty blockers and hormone therapy can create adverse health effects, including cardiovascular disease, infertility and risk of cancer.

The big picture: DeSantis (R) has become more vocal about these therapies, oftentimes opposing them. His administration asked the medical board to ban transition-related care for transgender minors in June.

Florida Surgeon General Joseph Ladapo asked board members in a letter earlier this year to adopt state guidelines for these treatments, per Click Orlando.

The Florida health department told doctors in April that they should not assist children and teens with gender transitions. This goes against federal guidance.

Go deeper ... DeSantis asks medical board to ban transgender health care

Florida advises against transition for transgender teens

Florida medical board looks to block gender-affirming treatments for minors

The board voted to approve gathering data and speaking with experts to build a standard of care for the state.

Illustration of a red circle, with the state of Florida forming a bar across it, with the transgender pride flag underneath.

Florida

The Centers for Disease Control and Prevention issued updated guidance Friday recommending that people limit their sexual partners while waiting to get vaccinated against monkeypox. 

Driving the news: While monkeypox is not considered a sexually transmitted disease, it is often transmitted through "close, sustained physical contact, which can include sexual contact," the CDC said.

Infections are overwhelmingly among men who have sex with men, data released by the CDC Friday shows.

However, anyone who has close contact with someone who is infectious is at risk, according to the World Health Organization.

Details: If a person or their partner suspects they have monkeypox, the best protection "is to avoid sex of any kind (oral, anal, vaginal) and kissing or touching each other’s bodies," the agency said.

To reduce the chances of being exposed to monkeypox if sexually active, the CDC recommends limiting the number of sex partners.

"Spaces like back rooms, saunas, sex clubs, or private and public sex parties, where intimate, often anonymous sexual contact with multiple partners occurs—are more likely to spread monkeypox," the agency said.

Condoms alone may not prevent exposure to monkeypox since the rash can occur on other parts of the body.

But, but, but: "Have virtual sex with no in-person contact," the CDC wrote.

Consider having sex with your clothes on or covering areas where the rash is present, reducing as much skin-to-skin contact as possible, the agency added as an alternative.

Context: The head of the WHO suggested last week that men who have sex with men should temporarily limit their number of sexual partners, according to the Washington Post.

The CDC guidance, however, is not as blunt and does not single out men who have sex with men. 

The big picture: The U.S. declared the monkeypox outbreak a public health emergency on Thursday.

There were 7,510 reported cases of monkeypox in the U.S. as of Friday, according to CDC data. 

That's up from less than 5,000 cases last week.

What's next: U.S. health officials said that said last week that 800,000 monkeypox vaccine doses will be made available for distribution. 

CDC: Limit sexual partners to avoid monkeypox

While monkeypox is not a sexually transmitted disease, it is often transmitted through close contact.

DC residents lined up at a monkeypox vaccination clinics on Aug. 5, 2022. Picture: Bill Clark/CQ-Roll Call, Inc via Getty Images

Monkeypox

A jury ruled that a pharmacist who refused to fill her prescription for a morning-after pill based on his "beliefs" did not discriminate, but did award her $25,000 for the emotional harm caused, NBC News reports. 

The big picture: The Supreme Court's decision to overturn Roe v. Wade earlier this summer has reignited debates over contraception and birth control.

Details: Andrea Anderson filed a lawsuit against a pharmacist, George Badeaux, claiming he violated the Minnesota Human Rights Act when he would not fill her prescription for birth control in 2019.

Badeaux, who is also a pastor, allegedly told Anderson that filling the prescription would go against his "beliefs," according to the lawsuit.

She later found a pharmacy 50 miles from her home that was willing to fill the prescription, the Washington Post reports.

Badeaux said during the trial he "wasn't seeking to interfere with what she wanted to do," but "was asking to be excused," per the Star Tribune.

What's next: Anderson, who is represented by lawyers from Gender Justice, plans to appeal the jury's verdict with the Minnesota Court of Appeal, NBC News reports.

“The jury was not deciding what the law is, they were deciding the facts of what happened here in this particular case," Gender Justice legal director Jess Braverman said in a statement.

"We will appeal this decision and won’t stop fighting until Minnesotans can get the health care they need without the interference of providers putting their own personal beliefs ahead of their legal and ethical obligations to their patients.”

Jury rules pharmacist who denied patient morning after pill did not discriminate

The jury did award the woman $25,000 for the emotional harm caused.

Plan-B, emergency contraceptive, and Take Action, another version of the contraceptive.

Plan-B, emergency contraceptive, and Take Action, another form of contraceptive. Photo: Jim Watson/AFP via Getty Images

Birth control

Monkeypox case numbers in the United Kingdom may have started to level off, British health officials said Friday.

Driving the news: Early signs show that the outbreak is plateauing in the region, with 2,859 confirmed cases reported since May, according to the UK Health Security Agency.

Go deeper: Health officials estimated last month that the outbreak was doubling in the region every two weeks, according to the Associated Press.

But in recent weeks, the number of new infections has dropped.

Analyses of the current U.K. outbreak shows that monkeypox continues to be transmitted "primarily in interconnected sexual networks of gay, bisexual, or other men who have sex with men," British health officials said.

Still, there have been a small number of women confirmed to have monkeypox, the agency said. 99% of all U.K. cases are in men, with only 22 cases identified in women.

What they're saying: "While the most recent data suggests the growth of the outbreak has slowed, we cannot be complacent," Meera Chand, director of clinical and emerging infections at the UK Health Security Agency, said.

"Be vigilant of and check yourself for monkeypox symptoms, including rashes and blisters," Chand added.

Meanwhile: The United States declared monkeypox a public health emergency just a day earlier.

The World Health Organization declared monkeypox a global emergency late last month.

Monkeypox has spread to more than 70 countries in the recent outbreak.

Go deeper ... What you need to know about the monkeypox vaccine 

1 in 5 Americans fear they'll get monkeypox

FDA considering "dose-sparing" approach to increase availability of Jynneos vaccine

U.K. officials say monkeypox cases beginning to level off

The number of new infections has dropped in recent weeks, but officials warned against complacency.

A vial containing the monkeypox vaccine is seen on July 23, 2022, in London, England. Picture: by Hollie Adams/Getty Images

The Food and Drug Administration is considering splitting doses of the Jynneos vaccine into fifths to increase supply amid the expanding monkeypox outbreak, FDA Commissioner Robert Califf said this week.

Driving the news: Under the "dose-sparing" approach, health care providers could use one vial of the vaccine to administer up to five doses without an impact on safety or efficacy, Califf said.

As the Department of Health and Human Services works with Jynneos' manufacturer to increase the availability of the vaccine, Califf said "dose-sparing" could provide a potential solution in the interim.

Between the lines: The new approach would require a different method of administration, or injection into the skin, Califf said at a briefing on Thursday. 

The Jynneos vaccine currently is administered with a subcutaneous injection, which goes into the fat layer underneath the skin.

The new "dose-sparing" approach would require intradermal administration, which goes into the dermis. The dermis lies just underneath the top layer of skin known as the epidermis. 

Califf noted that there are some advantages to this approach, such as an improved immune response to the vaccine.

What he's saying: "It's important to note that the overall safety and efficacy profile will not be sacrificed with this approach," Califf said. "Please know we've been exploring all scientifically feasible options, and we believe this could be a promising approach." 

"It's important to note that we will not be sacrificing the high-quality regulatory standards that Americans have come to expect," he added.

FDA considers "dose-sparing" to increase availability of Monkeypox vaccine

Health care providers could use one vial of the vaccine to administer up to five doses without an impact on safety or efficacy.

A vial of the Jynneos monkeypox vaccine at a pop-up vaccination clinic on August 3, 2022 in West Hollywood, California. Photo: Mario Tama/Getty Images

President Joe Biden tested positive for COVID-19 for the seventh consecutive day on Friday.

The big picture: Initially testing positive on July 22, Biden tested negative after five days of the antiviral Paxlovid treatment but has had a "rebound" COVID case since last Saturday. 

The 79-year-old president is fully vaccinated and received a second booster shot in March.

What they're saying: The president continues to feel "very well," Biden's doctor, Kevin O'Connor, wrote Friday.

"His cough has almost completely resolved," O'Connor added.

"His temperature, pulse, blood pressure, respiratory rate and oxygen saturation remain entirely normal. His lungs remain clear," O'Connor said. 

The doctor said Biden is continuing to follow "strict isolation measures," although he did speak at the Rose Garden on Friday.

For the record: The CDC says people can end their COVID isolation after five full days if they are fever-free for 24 hours without the use of fever-reducing medication and other symptoms have improved.

Biden has continued to test positive on an antigen test.

Antigen tests may remain positive for weeks to months after initial infection and may not always indicate contagiousness, according to the Centers for Disease Control and Prevention.

Be smart: "Rebound" cases of COVID-19 are possible for those who take Paxlovid, but it remains relatively rare, according to a Mayo Clinic study released in June.

"Paxlovid continues to be recommended for early stage treatment of mild to moderate COVID-19 among persons at high risk for progression to severe disease," the CDC said in May.

Biden tests positive for COVID for seventh day

The president has had a "rebound" case of COVID-19 since last Saturday.

President Joe Biden speaks at the White House on Aug. 5, 2022. Photo: Evan Vucci/Getty Images

Joe Biden

The United States has declared a public health emergency for monkeypox, raising awareness of the outbreak hitting more than 70 countries across the world. 

The big picture:  Two-thirds of Americans said in a survey from the Annenberg Public Policy Center that they don't think there's a vaccine for monkeypox or they aren't sure. But there is and here's what you need to know about it. 

There are two vaccines that are used to prevent monkeypox infections, per the Centers for Disease Control and Prevention.

The Jynneos vaccine, manufactured by the Danish company Bavarian Nordic, has been approved by the Food and Drug Administration to prevent monkeypox.

ACAM2000, which comes from the company Sanofi Pastuer Biologics, has been approved by the FDA for use against smallpox infection and for monkeypox under an expanded access application, the CDC said. ACAM2000 is found to have more side effects and a higher rate of adverse events. 

Both vaccines are smallpox vaccines, which are believed to be effective at preventing monkeypox. 

World Health Organization Director-General Tedros Adhanom Ghebreyesus said smallpox vaccines should not be widely used to treat monkeypox due to limited clinical trials and availability.

Worth noting: There is currently a limited supply of the Jynneos vaccine. The United States has been placing orders for the vaccine to handle the growing demand for vaccination, health officials told reporters Thursday.

The ACAM2000 has a larger supply of vaccines available, but the CDC does not recommend them for people with certain health conditions.

How many shots do the Jynneos vaccine and ACAM2000 require? 

Jynneos vaccine requires two shots. The immune response takes 14 days after the second dose, the CDC said.

ACAM2000 has one dose. It takes four weeks for the immune response to reach maximum strength, per the CDC.

Differences between Jynneos vaccine and ACAM2000

The Jynneos vaccine includes a live virus that doesn't replicate and is associated with fewer adverse effects, the CDC said. 

Health care providers are more comfortable distributing the vaccine, too, since it's given through needle injection.

The CDC says boosters are recommended every two years.

But ACAM2000 is distributed by multiple punctures, leading to potential scarring. The stainless steel needle is dipped into a reconstituted vaccine — a method often used for orthopoxvirus vaccinations, the CDC said.

The vaccine contains a virus capable of transmission to close contacts.

ACAM2000 has also been associated with side effects, like myocarditis.

Health officials recommend boosters for this vaccine every three years.

What you need to know about the monkeypox vaccine

There are currently two vaccines that are used to prevent monkeypox infections.

Sections

Axios Local

Axios gets you smarter, faster with news & information that matters.

About

Subscribe